BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TRACE T32 Program - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TRACE T32 Program
X-ORIGINAL-URL:https://trace.rutgers.edu
X-WR-CALDESC:Events for TRACE T32 Program
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261102T120000
DTEND;TZID=America/New_York:20261102T130000
DTSTAMP:20261006T053928
CREATED:20261005T154915Z
LAST-MODIFIED:20261005T164533Z
UID:715-1793620800-1793624400@trace.rutgers.edu
SUMMARY:iJOBS and Erdos Institute Seminar: AI in Clinical Research and Trials
DESCRIPTION:Artificial Intelligence is everywhere these days including where PhD scientists are involved in clinical trials and digital health. Join us to learn from Kamala Maddali\, DVM\, PhD about how she has founded a healthcare consulting and advisory firm focused on accelerating innovation across precision medicine\, diagnostics\, artificial intelligence\, and digital health. She will share how she has leveraged her computational skills to gain expertise in\n·       Precision Medicine & Companion Diagnostics (CDx) \n·       Oncology\, Neuroscience & Rare Disease Strategy \n·       AI/ML\, Multimodal Data & Real-World Evidence (RWE) \n·       Biomarkers\, Liquid Biopsy & Digital Pathology \n·       Pharma\, Diagnostics & Health System Partnerships \n·       Business Development & Commercial Strategy \n·       Academic\, Clinical & KOL Collaborations \n·       Market Access & Innovation Ecosystem Development \nNov 2 from 12-1pm\nTo register\, click here
URL:https://trace.rutgers.edu/event/ijobs-and-erdos-institute-seminar-ai-in-clinical-research-and-trials/
LOCATION:Virtual
CATEGORIES:For Trainees
END:VEVENT
END:VCALENDAR